MEDIA

Media Inquiries

Investors@OncoSec.com

855-662-6732

Press Releases

VIEW ALL PRESS RELEASES

Video Feed

3D MOA Animation video

✕

OncoSec's VLA 3D MOA Animation

✕

TAVO Demonstration with Dr Algazi

✕

OncoSec at 2020 BIO CEO Panel

✕

Tumor Immunogenicity

✕

IAD Reel

✕

IAD Robert Andtbacka, M.D.

✕

Social Media

Twitter Feed

OncoSec Medical@OncoSec·
4h

We're pleased to announce we have received authorization to CE mark our proprietary next generation go-to-market #GeneDeliveryDevice, a part of the OncoSec Medical System (OMS) electroporation device platform for the treatment of #SolidTumors. Learn more: http://bit.ly/2PVghui

OncoSec Medical@OncoSec·
13 Apr

We are proud to support the #Melanoma Exchange #Patient & #Advocate #Forum on April 15th & May 6th. This forum will provide information, insight and strategies to help navigate melanoma #diagnosis, #treatment or beyond. Learn more and register here: http://bit.ly/3dhO48w

OncoSec Medical@OncoSec·
12 Apr

As a proud sponsor of the 4th World Congress on Electroporation & Pulsed Electric Fields, we invite #GraduateStudents and #early_stage #researchers to apply for a #WCE2021 Travel Grant: http://bit.ly/3dg98wj

WCE2021@wce2021·
7 Apr

#WCE2021 POSTER AWARDS KINDLY SUPPORTED BY @OncoSec❗ We will award the best poster presentation within #oncology and #cancer research(1,000€) – All abstracts within cancer research (clinical, pre-clinical and veterinary) using electroporation may join.
➡️https://wc2021.electroporation.net/grants-and-awards/

Featured Articles

Melanoma Research Alliance

From Dermatology to Treatment: Second Opinions, Clinical Trials & becoming Your Own Best Advocate

PharmaVoice

Women of the Week interview with OncoSec’s Chief Clinical Development Officer, Kellie Malloy Foerter

Annals of Oncology

Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients

Clinical Cancer Research

Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma.